Publications since 2019


Tomicic MT, Steigerwald C, Rasenberger B, Brozovic A and Christmann M (2019) Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6. Arch Toxicol, doi: 10.1007/s00204-019-02513-7 Link

Neitzel C, Seiwert N, Göder A, Diehl E, Weber C, Nagel G, Stroh S, Rasenberger B, Christmann M and Fahrer J (2019) Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. Cells, doi: 10.3390/cells8080794 Link

Kaina B and Christmann M (2019) DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas.DNA Repair (Amst), doi: 10.1016/j.dnarep.2019.04.007 Link

Aasland D, Gotzinger L, Hauck L, Berte N, Meyer J, Effenberger M, Schneider S, Reuber EE, Roos WP, Tomicic MT, Kaina B and Christmann M (2019) Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR–Chk1, p21, and NF-kB. Cancer Res, doi: 10.1158/0008-5472.CAN-18-1733 Link